Healthtech Startups

CoverRight helps Medicare-eligible seniors in the U.S. find, compare and enroll in health insurance plans, combining online technology with licensed advisors to provide personalized plan recommendations. It serves the 65+ Medicare recipient market with tools and guidance for navigating coverage options.

4 investors

Covetrus provides a practice improvement platform for veterinary clinics, offering practice management software, payment processing, diagnostics, prescription and online pharmacy management, client communications, and supply/distribution services. It serves independent and corporate veterinary practices as well as suppliers, operating the VetSuite network used by veterinarians.

4 investors

Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.

4 investors

Cricket Health provides value-based kidney care, using a holistic approach to treat people with chronic kidney disease and related cardiovascular conditions. It works with payers and nephrologists to advance health equity and improve outcomes for patients with chronic conditions.

4 investors

CroíValve develops minimally invasive medical devices for treating tricuspid regurgitation, a heart valve condition. The company serves the cardiovascular/structural heart treatment market.

4 investors

CrowdMed connects patients with a community of medical experts ("Medical Detectives") to help solve complex, undiagnosed medical cases through crowdsourced diagnostic suggestions. Patients submit their medical history and symptoms, receive a report with top diagnostic recommendations, and can present these insights to their physicians for testing.

4 investors

Cryogenx develops CGX1, a portable body cooling device designed to treat heatstroke and prevent heat-related deaths. The company targets defense, first responder, sports, and industrial sectors with medical technology intended to rapidly reduce core body temperature.

4 investors

Crystalys Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for gout, a chronic metabolic disease caused by elevated uric acid. Its lead investigational therapy is a selective URAT1 inhibitor designed to lower serum uric acid by targeting renal urate reabsorption pathways.

4 investors

RejuvenAir, developed by CSA Medical, is a bronchoscopic cryosurgical device that sprays metered doses of liquid nitrogen to destroy damaged airway cells and treat the underlying cause of COPD with Chronic Bronchitis. The investigational device is being evaluated in the SPRAY-CB clinical trial at hospitals across the United States for interventional pulmonary care.

4 investors

Cuideo is a platform that connects families with screened home care professionals for elderly and dependent relatives in Spain. It offers services ranging from hourly care and live-in caregivers to telehealth monitoring, physiotherapy, and podiatry, with operations across more than 550 Spanish cities.

4 investors

Cumulus Oncology is a drug development company specializing in oncology therapeutics, leveraging experienced leadership with track records in new drug applications and successful M&A transactions. The company builds a risk-adjusted portfolio in the life sciences and pharmaceutical sector.

4 investors

CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling. It targets psychiatric and neurodegenerative conditions including Parkinson's disease, Alzheimer's disease, neurogenic orthostatic hypotension, PSP, and ALS.

4 investors

Curative offers an employer-sponsored health insurance plan with $0 copays, $0 deductibles, and a single monthly premium, giving members access to a nationwide provider network, telehealth, and $0 preferred prescriptions. The plan includes a cash card for out-of-pocket-free care and support from care navigators to help members manage their health.

4 investors

Cure51 is a cancer research company that decodes the biology of exceptional cancer survivors ("cancer outliers") using molecular profiling and computational biology, collecting patient data on its Patient Profile Platform. It works with cancer centers and clinical partners as part of the Rosalind Study to advance cancer research.

4 investors

HealthVerity operates a healthcare and consumer data ecosystem that enables HIPAA-compliant synchronization and exchange of real-world data across pharma, payers, and government agencies. The company combines disparate healthcare datasets to provide longitudinal patient insights and support research and innovation in the life sciences industry.

4 investors

Curocell is a Korean biotech company developing CAR-T cell therapies for cancers such as lymphoma and leukemia, as well as autoimmune conditions like lupus. Its lead therapy anbalcel (marketed as Limkato) received manufacturing/marketing approval, making it one of Korea's most advanced CAR-T-focused companies.

4 investors

Current Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings. It works with health systems and global pharmaceutical companies to expand patient access to high-cost treatments outside traditional hospital settings.

4 investors

Cylerity works in healthcare finance, using data to turn receivables into working capital and reduce operational friction. The company builds financial systems for the healthcare industry rather than relying on legacy models.

4 investors

Gilead Sciences is a biopharmaceutical company headquartered in Foster City, California that discovers, develops, and delivers medicines across virology, oncology, and inflammation. The company is investing $32 billion in U.S. operations through 2030 to expand its research infrastructure and create domestic jobs.

4 investors

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. Its lead program is being studied in combination with capecitabine and gemcitabine in a Phase 1/2 clinical trial that includes patients with advanced ovarian cancer.

4 investors

Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia. Its lead drug targets a specific subunit of the GABA-A receptor to improve neuronal function and reverse cognitive impairment.

4 investors

DaphOS is an AI software platform that provides predictive analytics and decision support for leaders in the healthcare, social services, and public sectors, helping identify risks and opportunities in areas like staffing, capacity utilization, and resource planning. It includes a data warehouse with anonymized reference data from over 150 healthcare facilities for benchmarking and AI model training.

4 investors

Datrics provides AI-powered medical coding software that processes healthcare insurance claims for providers, aiming to reduce errors and speed up claim handling.

4 investors

Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.

4 investors